Kindstar Globalgene Technology, Inc.
Kindstar Globalgene Technology, Inc. (9960.HK) Stock Competitors & Peer Comparison
See (9960.HK) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Care Facilities Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| 9960.HK | HK$1.15 | +0.88% | 1.1B | -16.43 | -HK$0.07 | +2.07% |
| 6618.HK | HK$48.96 | +0.66% | 156.7B | 25.63 | HK$1.91 | N/A |
| 1989.HK | HK$99.35 | -3.36% | 89.8B | 36.66 | HK$2.71 | N/A |
| 6078.HK | HK$12.35 | +1.31% | 7.6B | 39.84 | HK$0.31 | N/A |
| 1951.HK | HK$2.51 | +0.80% | 6.8B | -6.12 | -HK$0.41 | N/A |
| 2273.HK | HK$27.10 | +0.44% | 6.1B | 16.52 | HK$1.64 | +2.80% |
| 2609.HK | HK$4.34 | -4.82% | 5.7B | -144.67 | -HK$0.03 | N/A |
| 2373.HK | HK$19.50 | -2.26% | 4.9B | 12.58 | HK$1.55 | +2.67% |
| 1515.HK | HK$2.80 | +1.82% | 3.5B | 6.36 | HK$0.44 | +5.14% |
| 2508.HK | HK$4.48 | -2.82% | 2.8B | 14.45 | HK$0.31 | N/A |
Stock Comparison
9960.HK vs 6618.HK Comparison April 2026
9960.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 9960.HK stands at 1.1B. In comparison, 6618.HK has a market cap of 156.7B. Regarding current trading prices, 9960.HK is priced at HK$1.15, while 6618.HK trades at HK$48.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
9960.HK currently has a P/E ratio of -16.43, whereas 6618.HK's P/E ratio is 25.63. In terms of profitability, 9960.HK's ROE is -0.04%, compared to 6618.HK's ROE of +0.09%. Regarding short-term risk, 9960.HK is more volatile compared to 6618.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 9960.HK.Check 6618.HK's competition here
9960.HK vs 1989.HK Comparison April 2026
9960.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 9960.HK stands at 1.1B. In comparison, 1989.HK has a market cap of 89.8B. Regarding current trading prices, 9960.HK is priced at HK$1.15, while 1989.HK trades at HK$99.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
9960.HK currently has a P/E ratio of -16.43, whereas 1989.HK's P/E ratio is 36.66. In terms of profitability, 9960.HK's ROE is -0.04%, compared to 1989.HK's ROE of -0.16%. Regarding short-term risk, 9960.HK is less volatile compared to 1989.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 9960.HK.Check 1989.HK's competition here
9960.HK vs 6078.HK Comparison April 2026
9960.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 9960.HK stands at 1.1B. In comparison, 6078.HK has a market cap of 7.6B. Regarding current trading prices, 9960.HK is priced at HK$1.15, while 6078.HK trades at HK$12.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
9960.HK currently has a P/E ratio of -16.43, whereas 6078.HK's P/E ratio is 39.84. In terms of profitability, 9960.HK's ROE is -0.04%, compared to 6078.HK's ROE of +0.05%. Regarding short-term risk, 9960.HK is more volatile compared to 6078.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 9960.HK.Check 6078.HK's competition here
9960.HK vs 1951.HK Comparison April 2026
9960.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 9960.HK stands at 1.1B. In comparison, 1951.HK has a market cap of 6.8B. Regarding current trading prices, 9960.HK is priced at HK$1.15, while 1951.HK trades at HK$2.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
9960.HK currently has a P/E ratio of -16.43, whereas 1951.HK's P/E ratio is -6.12. In terms of profitability, 9960.HK's ROE is -0.04%, compared to 1951.HK's ROE of -0.11%. Regarding short-term risk, 9960.HK is more volatile compared to 1951.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 9960.HK.Check 1951.HK's competition here
9960.HK vs 2273.HK Comparison April 2026
9960.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 9960.HK stands at 1.1B. In comparison, 2273.HK has a market cap of 6.1B. Regarding current trading prices, 9960.HK is priced at HK$1.15, while 2273.HK trades at HK$27.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
9960.HK currently has a P/E ratio of -16.43, whereas 2273.HK's P/E ratio is 16.52. In terms of profitability, 9960.HK's ROE is -0.04%, compared to 2273.HK's ROE of +0.15%. Regarding short-term risk, 9960.HK is less volatile compared to 2273.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 9960.HK.Check 2273.HK's competition here
9960.HK vs 2609.HK Comparison April 2026
9960.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 9960.HK stands at 1.1B. In comparison, 2609.HK has a market cap of 5.7B. Regarding current trading prices, 9960.HK is priced at HK$1.15, while 2609.HK trades at HK$4.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
9960.HK currently has a P/E ratio of -16.43, whereas 2609.HK's P/E ratio is -144.67. In terms of profitability, 9960.HK's ROE is -0.04%, compared to 2609.HK's ROE of N/A. Regarding short-term risk, 9960.HK is less volatile compared to 2609.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 9960.HK.Check 2609.HK's competition here
9960.HK vs 2373.HK Comparison April 2026
9960.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 9960.HK stands at 1.1B. In comparison, 2373.HK has a market cap of 4.9B. Regarding current trading prices, 9960.HK is priced at HK$1.15, while 2373.HK trades at HK$19.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
9960.HK currently has a P/E ratio of -16.43, whereas 2373.HK's P/E ratio is 12.58. In terms of profitability, 9960.HK's ROE is -0.04%, compared to 2373.HK's ROE of +0.33%. Regarding short-term risk, 9960.HK is less volatile compared to 2373.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 9960.HK.Check 2373.HK's competition here
9960.HK vs 1515.HK Comparison April 2026
9960.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 9960.HK stands at 1.1B. In comparison, 1515.HK has a market cap of 3.5B. Regarding current trading prices, 9960.HK is priced at HK$1.15, while 1515.HK trades at HK$2.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
9960.HK currently has a P/E ratio of -16.43, whereas 1515.HK's P/E ratio is 6.36. In terms of profitability, 9960.HK's ROE is -0.04%, compared to 1515.HK's ROE of +0.08%. Regarding short-term risk, 9960.HK is more volatile compared to 1515.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 9960.HK.Check 1515.HK's competition here
9960.HK vs 2508.HK Comparison April 2026
9960.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 9960.HK stands at 1.1B. In comparison, 2508.HK has a market cap of 2.8B. Regarding current trading prices, 9960.HK is priced at HK$1.15, while 2508.HK trades at HK$4.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
9960.HK currently has a P/E ratio of -16.43, whereas 2508.HK's P/E ratio is 14.45. In terms of profitability, 9960.HK's ROE is -0.04%, compared to 2508.HK's ROE of N/A. Regarding short-term risk, 9960.HK is less volatile compared to 2508.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 9960.HK.Check 2508.HK's competition here
9960.HK vs 2522.HK Comparison April 2026
9960.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 9960.HK stands at 1.1B. In comparison, 2522.HK has a market cap of 2B. Regarding current trading prices, 9960.HK is priced at HK$1.15, while 2522.HK trades at HK$5.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
9960.HK currently has a P/E ratio of -16.43, whereas 2522.HK's P/E ratio is 564.00. In terms of profitability, 9960.HK's ROE is -0.04%, compared to 2522.HK's ROE of -0.02%. Regarding short-term risk, 9960.HK is less volatile compared to 2522.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 9960.HK.Check 2522.HK's competition here
9960.HK vs 2219.HK Comparison April 2026
9960.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 9960.HK stands at 1.1B. In comparison, 2219.HK has a market cap of 1.9B. Regarding current trading prices, 9960.HK is priced at HK$1.15, while 2219.HK trades at HK$2.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
9960.HK currently has a P/E ratio of -16.43, whereas 2219.HK's P/E ratio is 10.19. In terms of profitability, 9960.HK's ROE is -0.04%, compared to 2219.HK's ROE of +0.07%. Regarding short-term risk, 9960.HK is more volatile compared to 2219.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 9960.HK.Check 2219.HK's competition here
9960.HK vs 0708.HK Comparison April 2026
9960.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 9960.HK stands at 1.1B. In comparison, 0708.HK has a market cap of 1.8B. Regarding current trading prices, 9960.HK is priced at HK$1.15, while 0708.HK trades at HK$0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
9960.HK currently has a P/E ratio of -16.43, whereas 0708.HK's P/E ratio is -0.06. In terms of profitability, 9960.HK's ROE is -0.04%, compared to 0708.HK's ROE of +0.21%. Regarding short-term risk, 9960.HK is less volatile compared to 0708.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 9960.HK.Check 0708.HK's competition here
9960.HK vs 3886.HK Comparison April 2026
9960.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 9960.HK stands at 1.1B. In comparison, 3886.HK has a market cap of 1.7B. Regarding current trading prices, 9960.HK is priced at HK$1.15, while 3886.HK trades at HK$0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
9960.HK currently has a P/E ratio of -16.43, whereas 3886.HK's P/E ratio is -12.50. In terms of profitability, 9960.HK's ROE is -0.04%, compared to 3886.HK's ROE of +0.00%. Regarding short-term risk, 9960.HK is less volatile compared to 3886.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 9960.HK.Check 3886.HK's competition here
9960.HK vs 3309.HK Comparison April 2026
9960.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 9960.HK stands at 1.1B. In comparison, 3309.HK has a market cap of 1.5B. Regarding current trading prices, 9960.HK is priced at HK$1.15, while 3309.HK trades at HK$1.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
9960.HK currently has a P/E ratio of -16.43, whereas 3309.HK's P/E ratio is 16.38. In terms of profitability, 9960.HK's ROE is -0.04%, compared to 3309.HK's ROE of +0.06%. Regarding short-term risk, 9960.HK is more volatile compared to 3309.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 9960.HK.Check 3309.HK's competition here
9960.HK vs 1526.HK Comparison April 2026
9960.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 9960.HK stands at 1.1B. In comparison, 1526.HK has a market cap of 1.3B. Regarding current trading prices, 9960.HK is priced at HK$1.15, while 1526.HK trades at HK$0.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
9960.HK currently has a P/E ratio of -16.43, whereas 1526.HK's P/E ratio is 3.77. In terms of profitability, 9960.HK's ROE is -0.04%, compared to 1526.HK's ROE of +0.18%. Regarding short-term risk, 9960.HK is more volatile compared to 1526.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 9960.HK.Check 1526.HK's competition here
9960.HK vs 0383.HK Comparison April 2026
9960.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 9960.HK stands at 1.1B. In comparison, 0383.HK has a market cap of 1.1B. Regarding current trading prices, 9960.HK is priced at HK$1.15, while 0383.HK trades at HK$1.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
9960.HK currently has a P/E ratio of -16.43, whereas 0383.HK's P/E ratio is -52.00. In terms of profitability, 9960.HK's ROE is -0.04%, compared to 0383.HK's ROE of -0.01%. Regarding short-term risk, 9960.HK is more volatile compared to 0383.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 9960.HK.Check 0383.HK's competition here
9960.HK vs 6639.HK Comparison April 2026
9960.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 9960.HK stands at 1.1B. In comparison, 6639.HK has a market cap of 1B. Regarding current trading prices, 9960.HK is priced at HK$1.15, while 6639.HK trades at HK$1.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
9960.HK currently has a P/E ratio of -16.43, whereas 6639.HK's P/E ratio is 30.50. In terms of profitability, 9960.HK's ROE is -0.04%, compared to 6639.HK's ROE of +0.01%. Regarding short-term risk, 9960.HK is less volatile compared to 6639.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 9960.HK.Check 6639.HK's competition here
9960.HK vs 9906.HK Comparison April 2026
9960.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 9960.HK stands at 1.1B. In comparison, 9906.HK has a market cap of 936M. Regarding current trading prices, 9960.HK is priced at HK$1.15, while 9906.HK trades at HK$1.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
9960.HK currently has a P/E ratio of -16.43, whereas 9906.HK's P/E ratio is 78.00. In terms of profitability, 9960.HK's ROE is -0.04%, compared to 9906.HK's ROE of +0.02%. Regarding short-term risk, 9960.HK is more volatile compared to 9906.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 9960.HK.Check 9906.HK's competition here
9960.HK vs 2453.HK Comparison April 2026
9960.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 9960.HK stands at 1.1B. In comparison, 2453.HK has a market cap of 901.2M. Regarding current trading prices, 9960.HK is priced at HK$1.15, while 2453.HK trades at HK$1.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
9960.HK currently has a P/E ratio of -16.43, whereas 2453.HK's P/E ratio is -2.95. In terms of profitability, 9960.HK's ROE is -0.04%, compared to 2453.HK's ROE of -0.15%. Regarding short-term risk, 9960.HK is more volatile compared to 2453.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 9960.HK.Check 2453.HK's competition here
9960.HK vs 1846.HK Comparison April 2026
9960.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 9960.HK stands at 1.1B. In comparison, 1846.HK has a market cap of 865.9M. Regarding current trading prices, 9960.HK is priced at HK$1.15, while 1846.HK trades at HK$2.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
9960.HK currently has a P/E ratio of -16.43, whereas 1846.HK's P/E ratio is 11.25. In terms of profitability, 9960.HK's ROE is -0.04%, compared to 1846.HK's ROE of +0.06%. Regarding short-term risk, 9960.HK is more volatile compared to 1846.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 9960.HK.Check 1846.HK's competition here
9960.HK vs 3689.HK Comparison April 2026
9960.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 9960.HK stands at 1.1B. In comparison, 3689.HK has a market cap of 678.8M. Regarding current trading prices, 9960.HK is priced at HK$1.15, while 3689.HK trades at HK$2.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
9960.HK currently has a P/E ratio of -16.43, whereas 3689.HK's P/E ratio is 5.97. In terms of profitability, 9960.HK's ROE is -0.04%, compared to 3689.HK's ROE of +0.05%. Regarding short-term risk, 9960.HK is less volatile compared to 3689.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 9960.HK.Check 3689.HK's competition here
9960.HK vs 2120.HK Comparison April 2026
9960.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 9960.HK stands at 1.1B. In comparison, 2120.HK has a market cap of 597.7M. Regarding current trading prices, 9960.HK is priced at HK$1.15, while 2120.HK trades at HK$8.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
9960.HK currently has a P/E ratio of -16.43, whereas 2120.HK's P/E ratio is 9.87. In terms of profitability, 9960.HK's ROE is -0.04%, compared to 2120.HK's ROE of +0.04%. Regarding short-term risk, 9960.HK is more volatile compared to 2120.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 9960.HK.Check 2120.HK's competition here
9960.HK vs 3869.HK Comparison April 2026
9960.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 9960.HK stands at 1.1B. In comparison, 3869.HK has a market cap of 543.3M. Regarding current trading prices, 9960.HK is priced at HK$1.15, while 3869.HK trades at HK$3.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
9960.HK currently has a P/E ratio of -16.43, whereas 3869.HK's P/E ratio is 33.17. In terms of profitability, 9960.HK's ROE is -0.04%, compared to 3869.HK's ROE of +0.32%. Regarding short-term risk, 9960.HK is more volatile compared to 3869.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 9960.HK.Check 3869.HK's competition here
9960.HK vs 2189.HK Comparison April 2026
9960.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 9960.HK stands at 1.1B. In comparison, 2189.HK has a market cap of 475M. Regarding current trading prices, 9960.HK is priced at HK$1.15, while 2189.HK trades at HK$0.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
9960.HK currently has a P/E ratio of -16.43, whereas 2189.HK's P/E ratio is 23.75. In terms of profitability, 9960.HK's ROE is -0.04%, compared to 2189.HK's ROE of +0.05%. Regarding short-term risk, 9960.HK is less volatile compared to 2189.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 9960.HK.Check 2189.HK's competition here
9960.HK vs 2389.HK Comparison April 2026
9960.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 9960.HK stands at 1.1B. In comparison, 2389.HK has a market cap of 381.7M. Regarding current trading prices, 9960.HK is priced at HK$1.15, while 2389.HK trades at HK$0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
9960.HK currently has a P/E ratio of -16.43, whereas 2389.HK's P/E ratio is -6.30. In terms of profitability, 9960.HK's ROE is -0.04%, compared to 2389.HK's ROE of -0.05%. Regarding short-term risk, 9960.HK is less volatile compared to 2389.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 9960.HK.Check 2389.HK's competition here
9960.HK vs 0722.HK Comparison April 2026
9960.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 9960.HK stands at 1.1B. In comparison, 0722.HK has a market cap of 360.9M. Regarding current trading prices, 9960.HK is priced at HK$1.15, while 0722.HK trades at HK$0.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
9960.HK currently has a P/E ratio of -16.43, whereas 0722.HK's P/E ratio is 11.13. In terms of profitability, 9960.HK's ROE is -0.04%, compared to 0722.HK's ROE of +0.04%. Regarding short-term risk, 9960.HK is more volatile compared to 0722.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 9960.HK.Check 0722.HK's competition here
9960.HK vs 1419.HK Comparison April 2026
9960.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 9960.HK stands at 1.1B. In comparison, 1419.HK has a market cap of 311.2M. Regarding current trading prices, 9960.HK is priced at HK$1.15, while 1419.HK trades at HK$0.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
9960.HK currently has a P/E ratio of -16.43, whereas 1419.HK's P/E ratio is 11.71. In terms of profitability, 9960.HK's ROE is -0.04%, compared to 1419.HK's ROE of +0.04%. Regarding short-term risk, 9960.HK is more volatile compared to 1419.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 9960.HK.Check 1419.HK's competition here
9960.HK vs 8405.HK Comparison April 2026
9960.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 9960.HK stands at 1.1B. In comparison, 8405.HK has a market cap of 276M. Regarding current trading prices, 9960.HK is priced at HK$1.15, while 8405.HK trades at HK$0.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
9960.HK currently has a P/E ratio of -16.43, whereas 8405.HK's P/E ratio is 9.86. In terms of profitability, 9960.HK's ROE is -0.04%, compared to 8405.HK's ROE of +0.12%. Regarding short-term risk, 9960.HK is more volatile compared to 8405.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 9960.HK.Check 8405.HK's competition here
9960.HK vs 1518.HK Comparison April 2026
9960.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 9960.HK stands at 1.1B. In comparison, 1518.HK has a market cap of 263.5M. Regarding current trading prices, 9960.HK is priced at HK$1.15, while 1518.HK trades at HK$0.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
9960.HK currently has a P/E ratio of -16.43, whereas 1518.HK's P/E ratio is -2.00. In terms of profitability, 9960.HK's ROE is -0.04%, compared to 1518.HK's ROE of -0.25%. Regarding short-term risk, 9960.HK is less volatile compared to 1518.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 9960.HK.Check 1518.HK's competition here
9960.HK vs 0286.HK Comparison April 2026
9960.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 9960.HK stands at 1.1B. In comparison, 0286.HK has a market cap of 251.8M. Regarding current trading prices, 9960.HK is priced at HK$1.15, while 0286.HK trades at HK$1.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
9960.HK currently has a P/E ratio of -16.43, whereas 0286.HK's P/E ratio is -0.86. In terms of profitability, 9960.HK's ROE is -0.04%, compared to 0286.HK's ROE of -0.22%. Regarding short-term risk, 9960.HK is more volatile compared to 0286.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 9960.HK.Check 0286.HK's competition here
9960.HK vs 2293.HK Comparison April 2026
9960.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 9960.HK stands at 1.1B. In comparison, 2293.HK has a market cap of 160.2M. Regarding current trading prices, 9960.HK is priced at HK$1.15, while 2293.HK trades at HK$0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
9960.HK currently has a P/E ratio of -16.43, whereas 2293.HK's P/E ratio is 10.00. In terms of profitability, 9960.HK's ROE is -0.04%, compared to 2293.HK's ROE of +0.07%. Regarding short-term risk, 9960.HK is more volatile compared to 2293.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 9960.HK.Check 2293.HK's competition here
9960.HK vs 8143.HK Comparison April 2026
9960.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 9960.HK stands at 1.1B. In comparison, 8143.HK has a market cap of 124M. Regarding current trading prices, 9960.HK is priced at HK$1.15, while 8143.HK trades at HK$0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
9960.HK currently has a P/E ratio of -16.43, whereas 8143.HK's P/E ratio is -3.67. In terms of profitability, 9960.HK's ROE is -0.04%, compared to 8143.HK's ROE of -5.74%. Regarding short-term risk, 9960.HK is more volatile compared to 8143.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 9960.HK.Check 8143.HK's competition here
9960.HK vs 8357.HK Comparison April 2026
9960.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 9960.HK stands at 1.1B. In comparison, 8357.HK has a market cap of 84.9M. Regarding current trading prices, 9960.HK is priced at HK$1.15, while 8357.HK trades at HK$0.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
9960.HK currently has a P/E ratio of -16.43, whereas 8357.HK's P/E ratio is -13.60. In terms of profitability, 9960.HK's ROE is -0.04%, compared to 8357.HK's ROE of -0.27%. Regarding short-term risk, 9960.HK is less volatile compared to 8357.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 9960.HK.Check 8357.HK's competition here
9960.HK vs 2135.HK Comparison April 2026
9960.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 9960.HK stands at 1.1B. In comparison, 2135.HK has a market cap of 84.7M. Regarding current trading prices, 9960.HK is priced at HK$1.15, while 2135.HK trades at HK$0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
9960.HK currently has a P/E ratio of -16.43, whereas 2135.HK's P/E ratio is -1.09. In terms of profitability, 9960.HK's ROE is -0.04%, compared to 2135.HK's ROE of -0.64%. Regarding short-term risk, 9960.HK is less volatile compared to 2135.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 9960.HK.Check 2135.HK's competition here
9960.HK vs 8307.HK Comparison April 2026
9960.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 9960.HK stands at 1.1B. In comparison, 8307.HK has a market cap of 56.7M. Regarding current trading prices, 9960.HK is priced at HK$1.15, while 8307.HK trades at HK$0.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
9960.HK currently has a P/E ratio of -16.43, whereas 8307.HK's P/E ratio is -14.30. In terms of profitability, 9960.HK's ROE is -0.04%, compared to 8307.HK's ROE of -0.56%. Regarding short-term risk, 9960.HK is more volatile compared to 8307.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 9960.HK.Check 8307.HK's competition here
9960.HK vs 8161.HK Comparison April 2026
9960.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 9960.HK stands at 1.1B. In comparison, 8161.HK has a market cap of 22.5M. Regarding current trading prices, 9960.HK is priced at HK$1.15, while 8161.HK trades at HK$0.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
9960.HK currently has a P/E ratio of -16.43, whereas 8161.HK's P/E ratio is 2.45. In terms of profitability, 9960.HK's ROE is -0.04%, compared to 8161.HK's ROE of +1.39%. Regarding short-term risk, 9960.HK is less volatile compared to 8161.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 9960.HK.Check 8161.HK's competition here
9960.HK vs 8437.HK Comparison April 2026
9960.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 9960.HK stands at 1.1B. In comparison, 8437.HK has a market cap of 16.7M. Regarding current trading prices, 9960.HK is priced at HK$1.15, while 8437.HK trades at HK$0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
9960.HK currently has a P/E ratio of -16.43, whereas 8437.HK's P/E ratio is -0.53. In terms of profitability, 9960.HK's ROE is -0.04%, compared to 8437.HK's ROE of +0.14%. Regarding short-term risk, 9960.HK is more volatile compared to 8437.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 9960.HK.Check 8437.HK's competition here